NSVLF yields 444.44% · PFE yields 6.13%● Live data
📍 NSVLF pulled ahead of the other in Year 1
Combined, NSVLF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NSVLF + PFE for your $10,000?
AuQ Gold Mining Inc., an exploration stage company, engages in the exploration of resource properties in Canada. It primarily explores for gold deposits. The company holds 100% interest in the Kirkland Creek gold property comprising 144 claims that covers an area of total 7,300 acres approximately located in the Ashihik Lake region to the northwest of Whitehorse, Yukon; and the Partridge gold project that comprises 95 mineral claims covering 52.68 square kilometers situated in Abitibi, Quebec. It also has an option to acquire a 100% interest in Sainte Sabine property located in the Beauce region of Quebec; and the Eliza Gold Project consisting of 8 mineral claims situated in Quebec. The company was formerly known as Royal Gold Mining Inc. and changed its name to AuQ Gold Mining Inc. in October 2020. AuQ Gold Mining Inc. was incorporated in 2005 and is based in Vancouver, Canada.
Full NSVLF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.